HOWL

WEREWOLF THERAPEUTICS INC

HOWL·95075A107·US·Common Stock·Healthcare - Biotechnology-Activist

HOWL (WEREWOLF THERAPEUTICS INC) is held by 32 institutional investors as of Q1 2026. Largest holders: RA CAPITAL MANAGEMENT, L.P. ($5.6M), VANGUARD CAPITAL MANAGEMENT LLC ($1M), RENAISSANCE TECHNOLOGIES LLC ($429,803). Net institutional sentiment: Mixed.

32
Holders
(3 Elite)
$8.5M
Total Value
45% (33)
Consensus
15 buying - 18 selling
13F: Insider & Congress: Updated regularly
HOWL

Smart Money Verdict

View all
Loading verdict
Held by 32 funds
3 elite

Who's Trading

Source dates: Price Aug 14, 2026 · Insiders May 12, 2026 · Activists Jul 2, 2026 · Congress none

ActivistRA Capital Management, L.P.RA Capital Management, L.P.4.1%Jul 2, 2026
ActivistRA Capital Management, L.P.RA Capital Management, L.P.6.0%Jun 26, 2026
ActivistRA Capital Management, L.P.RA Capital Management, L.P.7.5%Jun 22, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Unchanged
6.7M$5.6M0.1%-96.32%
0
New
1.2M$1M0.0%-31.36%
38
Decreased
516,218(-23.8%)$429,8030.0%-68.42%
0
Increased
389,487(+16.0%)$324,3630.0%-88.30%
18
Decreased
264,583(-64.1%)$220,1330.0%-72.44%
0
New
157,726$131,3860.0%-31.36%
34
Decreased
132,050(-45.0%)$109,9450.0%-84.14%
0
Unchanged
119,168$99,2190.0%-84.14%
0
Decreased
101,608(-0.0%)$84,5980.0%-72.59%
0
Unchanged
86,851$72,3120.0%-82.43%
0
Decreased
86,554(-63.3%)$72,0650.0%-95.50%
0
Decreased
82,836(-47.4%)$68,9690.0%-60.29%
0
Increased
66,857(+10.1%)$55,6920.0%-54.79%
16
New
50,929$42,4030.0%-31.36%
28
Increased
38,266(+12.3%)$31,8600.0%-65.52%
15
Decreased
33,799(-26.5%)$28,1410.0%-67.66%
0
Increased
32,526(+35.2%)$27,0940.0%-65.33%
17
New
19,778$16,4670.0%-31.36%
28
Decreased
13,235(-0.0%)$11,0200.0%-82.55%
0
New
10,382$8,6440.0%-31.36%
25

Showing 1-20 of 40

1 / 2
HOWLHOWLWEREWOLF THERAPEUTICS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used